What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
Petrini P. Petrini P.
.
.
Curr Drug Abuse Rev. 2010 Jun;3(2):76-9. doi: 10.2174/1874473711003020076. Curr Drug Abuse Rev. 2010. PMID: 20712591 Review.
.
. McCarthy CG, et al. JCI Insight. 2021 Sep 9:149037. doi: 10.1172/jci.insight.149037. Online ahead of print. JCI Insight. 2021. PMID: 34499623
. Goh JXH, et al. Cancers (Basel). 2019 Jun 21;11(6):867. doi: 10.3390/cancers11060867. Cancers (Basel). 2019. PMID: 31234411
.
Item in Clipboard
.
Bentham R, et al. Nature. 2021 Sep;597(7877):555-560. doi: 10.1038/s41586-021-03894-5. Epub 2021 Sep 8. Nature. 2021. PMID: 34497419